Distinct genetic modifiers of endothelial cell responses to oxidative stress and inflammation, including polymorphic variants of distinct members of the CYP, MMP and TLR4 gene families, have been indeed reported to impact the severity of CCM disease [20,21,35,51]. This evidence concerns the gene TLR4 and cerebral cavernous malformation.